Searchable abstracts of presentations at key conferences in endocrinology

ea0049ep1381 | Thyroid (non-cancer) | ECE2017

BRAFV600E status and Stimulated Thyroglobulin at ablation time increase prognostic value of American Thyroid Association (ATA) classification systems for persistent disease in Differentiated Thyroid Carcinoma (DTC)

Repaci Andrea , Vicennati Valentina , Paccapelo Alexandro , Salituro Nicola , Cavicchi Ottavio , Monari Fabio , Tallini Giovanni , Gruppioni Elisa , Altimari Annalisa , Fiorentino Michelangelo , Pagotto Uberto

Background: Stimulated Thyroglobulin levels measured at the time of remnant ablation (Htg-A) and BRAFV600E mutation were shown to have prognostic value in predicting persistent disease in DTC. The aim of this study was to evaluate the prognostic role of Htg-A combined with BRAFV600E status in association with revised American Thyroid Association (ATA) risk stratification.Patients and methods: 620 patients treated for a DTC were included in this study wit...